FDA vaccine chief Vinay Prasad leaves following criticism from Laura Loomer
WASHINGTON (AP) — The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief…
US health officials crack down on kratom-related products after complaints
WASHINGTON (AP) — U.S. health officials are warning Americans about the risks of an opioid-related ingredient increasingly added…
FDA names former pharmaceutical company executive George Tidmarsh to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the…
Sarepta tells FDA it won’t halt shipments of muscular dystrophy therapy despite patient deaths
WASHINGTON (AP) — Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food…
Sarepta stock falls on FDA gene therapy Elevidys comment
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New…
FDA to consider drug affordability when speeding up approvals: Makary
The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals…